Clinical Trials Sponsored by Allgemeine Ortskrankenkasse (AOK) Nordwest
Total 1 results
-
University of Southern DenmarkEsbjerg Municipality; Municipality of Slagelse; Municipality of Odense; Christian... and other collaboratorsCompleted
Sponsors and Collaborators
- National Anti Doping Laboratory, Belarus
- Second Baptist Church
- Huijuan Ruan
- Jinan City Dermatology Hospital Prevention and Treatment
- Rajiv Gandhi University of Health Sciences
- Axon Optics, LLC
- Federal State Budgetary Healthcare Institution, Hospital RAS
- Alliance for Clinical Trials in Oncology Cancer Control Program (CCP)
- Exsar Corporation
- German Centre of Cardiovascular Research (DZHK)
- JenaValve Technology, Inc.
- ArtemiLife
- National Institute of Cardiovascular Diseases, Karachi
- H & J CRO International, Inc.
- Cleveland Eye Clinic
- Knop Laboratorios
- BMS Canada Risk Services Ltd.
- Trimbos-institute (also primary organization conducting the study)
- Curis, Inc.
- Mark van Tilburg
- View Full List
Medical Conditions
- Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Post Stroke Epilepsy
- Benign or Malignant Tumour of the Oral Cavity
- Poor Mental Health
- Thorax Cancer
- Head Injury With Intracranial Hemorrhage
- Malignant Liver Disease
- Cancer-related Pain
- Percutaneous Coronary Revascularisation
- Tense Ascites
- Ischemia, Cerebral
- Breast, Cervical or Colorectal Cancer Screening Needed
- HER2-positive Carcinoma of Breast
- Families Experiencing Homelessness With Children Under 48 Months of Age
- Smallpox
- ASA I
- Explicit Recall of Intra-Operative Events
- Post-PV MF
- Tibial Shaft Fracture With or Without Associated Fibula Fracture
- Single Photon Emission Computed Tomography
- View Full List
Drug Interventions
- Deuteporfin
- Injectable naltrexone
- AMT-101 (oral)-Dose B
- PF-04965842
- Clopid® 75 mg Tablet
- TIP treatment (paclitaxel/ifosfamide/cisplatin)
- Vaginal estrogen
- Bupivacaine
- Fludarabine
- Topical Prednisolone Acetate 1%
- Pyridostigmine
- Clobazam
- Cyclophosphamide
- FOLFOX
- Ivermectin
- Cardene® I.V.
- L-Asparaginase
- Intravenous ibuprofen
- BI 1810631 - trial formulation 1 (TF1)
- OC514 (Low dose)
- View Full List
CROs by country
- Contract Research Organizations in Bangladesh
- Contract Research Organizations in Gambia
- Contract Research Organizations in Indonesia
- Contract Research Organizations in Jordan
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Nigeria
- Contract Research Organizations in Oman
- Contract Research Organizations in Pakistan
- Contract Research Organizations in Senegal
- Contract Research Organizations in South Africa
- Contract Research Organizations in Suriname
- Contract Research Organizations in Trinidad & Tobago
- Contract Research Organizations in United States
- CRO list by country